Vaccine Technology

mRNA Technology mRNA Vaccines Virus-Like Particles Clinical Trials Viral Vaccines DNA Vaccines Infectious Diseases Manufacturing Processes Vaccine Design Recombinant Vaccines

3 ARTICLES

last wk.

Soligenix Highlights ThermoVax Thermostable Filovirus Vaccine Claims as Stock Surges

Presenting preclinical primate protection with FDA orphan-drug status as advantages, Soligenix says its ThermoVax platform could ease cold-chain limits while human clinical proof remains absent.

3 ARTICLES

last wk.

Colombia Signs Deal With SK Bioscience to Build Domestic Vaccine Production

4 ARTICLES

3mo ago

CEPI Taps Samsung Biologics to Pre-Position Rapid Vaccine Manufacturing for Future Outbreaks

4 ARTICLES

4mo ago

UVA Team Tests DNA-Programmed Bacterial Vaccine Platform Aimed at Weeks-Long Development

3 ARTICLES

4mo ago

CEPI Backs Next-Gen Zaire Ebola Vaccine With $30 Million Routed Through MSD

5 ARTICLES

5mo ago

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

3 ARTICLES

8mo ago

Thermostable, Single-Injection Rabies Vaccine From CU Boulder Reports Strong Mouse Data

3 ARTICLES

8mo ago

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

30 ARTICLES

last yr.

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program

3 ARTICLES

last yr.

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development

5 ARTICLES

last yr.

Moderna Secures $176M to Develop mRNA Bird Flu Vaccine

8 ARTICLES

2y ago

Experimental mRNA Vaccine Extends Survival in Glioblastoma Patients

Vaccine Technology

Soligenix Highlights ThermoVax Thermostable Filovirus Vaccine Claims as Stock Surges

Colombia Signs Deal With SK Bioscience to Build Domestic Vaccine Production

CEPI Taps Samsung Biologics to Pre-Position Rapid Vaccine Manufacturing for Future Outbreaks

UVA Team Tests DNA-Programmed Bacterial Vaccine Platform Aimed at Weeks-Long Development

CEPI Backs Next-Gen Zaire Ebola Vaccine With $30 Million Routed Through MSD

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Thermostable, Single-Injection Rabies Vaccine From CU Boulder Reports Strong Mouse Data

Hipra Opens Aiguaviva Biotech Campus to Scale EU Vaccine Manufacturing

US Cuts $500 Million in mRNA Vaccine Research Funding

HHS Pulls Funding From 22 mRNA Vaccine Programs

Never miss stories about

Vaccine Technology

HHS Halts $500 Million in mRNA Vaccine Development Funding

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development

Moderna Secures $176M to Develop mRNA Bird Flu Vaccine

Experimental mRNA Vaccine Extends Survival in Glioblastoma Patients

Never miss stories about

Vaccine Technology